Top 5 Consumer Service Stocks To Buy Right Now: Oppenheimer Holdings Inc.(OPY)
Oppenheimer Holdings Inc., through its subsidiaries, operates as a middle-market investment bank and full service broker-dealer. It offers full-service brokerage services covering various investment alternatives, such as exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange-traded options and futures contracts, municipal bonds, mutual funds, and unit investment trusts. The company also provides financial and wealth planning services; margin lending; securities lending; and online equity investing and discount brokerage services. In addition, it offers asset management services for equity, fixed income, large-cap balanced, and alternative investments offered through vehicles, such as privately managed accounts, and retail and institutional separate accounts. Further, the company provides strategic advisory services and capital markets products; institutional equity sales and trading; equity research; equity options and derivatives; convertible bonds; and event driven sales and trading services. Additionally, it trades in non-investment grade public and private debt securities, mortgage-backed securities, sovereign and corporate debt, and distressed securities; provides fixed income research, public finance, and municipal trading services; and is involved in proprietary trading and investment activities. The company also participates in loan syndications and operates as underwriting agent in financing transactions; trades syndicated corporate loans in the secondary market; offers various trust services; and provides mortgage services to developers of commercial properties. It serves high-net-worth individuals and families, corporate executives, small and mid-sized businesses, endowments and foundations, and institutions in the United States, Europe, the Middle East, ! Asia, and South America. The company was founded in 1977 and is headquartered in New York, New York.
Advisors' Opinion:- [By Hilary Kramer]
With this news, some Wall Street firms finally — albeit a bit late — jumped on the ICPT bandwagon. Citigroup (C) raised its target to $400, stating that its market cap (at the time $5.4 billion) didn't reach the opportunity for these liver disease treatments. They estimated that the OCA could exceed a $5 billion sales level. Oppenheimer (OPY) also raised its target to $360 while Bank of America/Merrill’s (BAC) target is set at $872, the only one not yet exceeded with the most recent move.
source from Top Stocks For 2015:http://www.topstocksblog.com/top-5-consumer-service-stocks-to-buy-right-now.html
No comments:
Post a Comment